160 related articles for article (PubMed ID: 31882290)
1. Influence of Ethnicity on Clinical Presentation and Quality of Life in Women With Uterine Fibroids: Results From a Prospective Observational Registry.
Murji A; Bedaiwy M; Singh SS; Bougie O;
J Obstet Gynaecol Can; 2020 Jun; 42(6):726-733.e1. PubMed ID: 31882290
[TBL] [Abstract][Full Text] [Related]
2. Role of ethnicity in treating uterine fibroids with ulipristal acetate.
Murji A; Crosier R; Chow T; Ye XY; Shirreff L
Fertil Steril; 2016 Oct; 106(5):1165-1169. PubMed ID: 27336213
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
4. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women.
Marsh EE; Al-Hendy A; Kappus D; Galitsky A; Stewart EA; Kerolous M
J Womens Health (Larchmt); 2018 Nov; 27(11):1359-1367. PubMed ID: 30230950
[TBL] [Abstract][Full Text] [Related]
5. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of the psychosocial impact of fibroids before and after treatment.
Go VAA; Thomas MC; Singh B; Prenatt S; Sims H; Blanck JF; Segars JH
Am J Obstet Gynecol; 2020 Nov; 223(5):674-708.e8. PubMed ID: 32474012
[TBL] [Abstract][Full Text] [Related]
7. Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF Fibroid Registry.
Laughlin-Tommaso SK; Lu D; Thomas L; Diamond MP; Wallace K; Wegienka G; Vines AI; Anchan RM; Wang T; Maxwell GL; Jacoby V; Marsh EE; Spies JB; Nicholson WK; Stewart EA; Myers ER
Am J Obstet Gynecol; 2020 Apr; 222(4):345.e1-345.e22. PubMed ID: 31678093
[TBL] [Abstract][Full Text] [Related]
8. Impact of uterine fibroids on quality of life: a national cross-sectional survey.
Hervé F; Katty A; Isabelle Q; Céline S
Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():32-37. PubMed ID: 30099225
[TBL] [Abstract][Full Text] [Related]
9. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
10. One year symptom severity and health-related quality of life changes among Black African patients undergoing uterine fibroid embolisation.
Mariara C; Obura T; Hacking N; Stones W
BMC Res Notes; 2017 Jul; 10(1):240. PubMed ID: 28676073
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids.
Wallace K; Zhang S; Thomas L; Stewart EA; Nicholson WK; Wegienka GR; Wise LA; Laughlin-Tommaso SK; Diamond MP; Marsh EE; Jacoby VL; Anchan RM; Venable S; Larry GM; Lytle B; Wang T; Myers ER
Fertil Steril; 2020 Mar; 113(3):618-626. PubMed ID: 32192594
[TBL] [Abstract][Full Text] [Related]
12. Comparison of characteristics of fibroids in African American and white women undergoing premenopausal hysterectomy.
Moorman PG; Leppert P; Myers ER; Wang F
Fertil Steril; 2013 Mar; 99(3):768-776.e1. PubMed ID: 23199610
[TBL] [Abstract][Full Text] [Related]
13. The association between self-reported major life events and the presence of uterine fibroids.
Vines AI; Ta M; Esserman DA
Womens Health Issues; 2010; 20(4):294-8. PubMed ID: 20627775
[TBL] [Abstract][Full Text] [Related]
14. Uterine Fibroid Symptom and Health-related Quality of Life Questionnaire: a Chinese translation and validation study.
Yeung SY; Kwok JWK; Law SM; Chung JPW; Chan SSC
Hong Kong Med J; 2019 Dec; 25(6):453-459. PubMed ID: 31796639
[TBL] [Abstract][Full Text] [Related]
15. Growth of uterine leiomyomata among premenopausal black and white women.
Peddada SD; Laughlin SK; Miner K; Guyon JP; Haneke K; Vahdat HL; Semelka RC; Kowalik A; Armao D; Davis B; Baird DD
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19887-92. PubMed ID: 19047643
[TBL] [Abstract][Full Text] [Related]
16. A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014.
Yu O; Scholes D; Schulze-Rath R; Grafton J; Hansen K; Reed SD
Am J Obstet Gynecol; 2018 Dec; 219(6):591.e1-591.e8. PubMed ID: 30291840
[TBL] [Abstract][Full Text] [Related]
17. Impact of diagnosis and treatment of uterine fibroids on quality of life and labor productivity: The Japanese online survey for uterine fibroids and quality of life (JOYFUL survey).
Koga K; Fukui M; Fujisawa M; Suzukamo Y
J Obstet Gynaecol Res; 2023 Oct; 49(10):2528-2537. PubMed ID: 37524334
[TBL] [Abstract][Full Text] [Related]
18. The Ontario Uterine Fibroid Embolization Trial. Part 1. Baseline patient characteristics, fibroid burden, and impact on life.
Pron G; Cohen M; Soucie J; Garvin G; Vanderburgh L; Bell S;
Fertil Steril; 2003 Jan; 79(1):112-9. PubMed ID: 12524073
[TBL] [Abstract][Full Text] [Related]
19. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race.
Marshall LM; Spiegelman D; Barbieri RL; Goldman MB; Manson JE; Colditz GA; Willett WC; Hunter DJ
Obstet Gynecol; 1997 Dec; 90(6):967-73. PubMed ID: 9397113
[TBL] [Abstract][Full Text] [Related]
20. Evidence that geographic variation in genetic ancestry associates with uterine fibroids.
Keaton JM; Jasper EA; Hellwege JN; Jones SH; Torstenson ES; Edwards TL; Velez Edwards DR
Hum Genet; 2021 Oct; 140(10):1433-1440. PubMed ID: 34302236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
